BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36294547)

  • 1. Case Report with Systematic Literature Review on Vascular Complications of BCG Intravesical Therapy for Bladder Cancer.
    King B; Singh D; Rathore A; Flenner R; Flemmer M
    J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal aortic aneurysmal and endovascular device infection with iliopsoas abscess caused by Mycobacterium bovis as a complication of intravesical bacillus Calmette-Guérin therapy.
    Mizoguchi H; Iida O; Dohi T; Tomoda K; Kimura H; Inoue K; Iwata T; Tei K; Miura T
    Ann Vasc Surg; 2013 Nov; 27(8):1186.e1-5. PubMed ID: 23972639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium Bovis Causing Mycotic Aneurysm Secondary to Intravesical Treatment with Bacillus Calmette-Guérin: A Case Report.
    Zaza SI; Ghasemzadeh A; Bennett KM
    Ann Vasc Surg; 2022 Feb; 79():437.e1-437.e6. PubMed ID: 34644643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular graft infections caused by
    Arsuffi S; Cambianica A; Di Filippo E; Ripamonti D; Tebaldi A; Arosio MEG; Farina CF; Rizzi M
    J Clin Tuberc Other Mycobact Dis; 2023 May; 31():100360. PubMed ID: 36941969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
    Shepherd AR; Shepherd E; Brook NR
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aorto-enteric fistula development secondary to mycotic abdominal aortic aneurysm following intravesical bacillus Calmette-Guerin (BCG) treatment for transitional cell carcinoma of the bladder.
    Roylance A; Mosley J; Jameel M; Sylvan A; Walker V
    Int J Surg Case Rep; 2013; 4(1):88-90. PubMed ID: 23127864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining optimal maintenance schedules for adjuvant intravesical bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis.
    Huang Z; Liu H; Wang Y; Zhang C; Xu T
    Curr Med Res Opin; 2017 Aug; 33(8):1379-1387. PubMed ID: 28471272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Randomized Controlled Study of Intravesical Instillation Therapy of Bacillus Calmette-Guérin vs. Epirubicinin Treating Non-muscular Invasive Bladder Cancer].
    Yang WX; Shao YX; Hu X; Xiong SC; Liu Y; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):326-333. PubMed ID: 33829710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycotic arterial aneurysm secondary to BCG intravesical instillation: A review.
    Palmier M; Monnot A; Tenière T; Cohen Q; Plissonnier D
    J Med Vasc; 2022 Apr; 47(2):94-105. PubMed ID: 35691669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacille Calmette-Guérin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review.
    Kusakabe T; Endo K; Nakamura I; Suzuki H; Nishimura H; Fukushima S; Yamamoto K
    BMC Infect Dis; 2018 Jun; 18(1):290. PubMed ID: 29954321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer.
    Bajramovic S; Alic J; Skopljak E; Chikha A; Vesnic S; Smajilbegovic V; Aganovic D
    Med Arch; 2020 Apr; 74(2):146-150. PubMed ID: 32577059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aortic Complications Related to Mycobacterium bovis after Intravesical Bacille Calmette-Guérin Therapy - a Systematic Review].
    Buerger M; Kapahnke S; Omran S; Müller V; Hinterseher I; Greiner A; Frese JP
    Zentralbl Chir; 2021 Oct; 146(5):506-520. PubMed ID: 34666364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guérin.
    Li R; Sundi D; Zhang J; Kim Y; Sylvester RJ; Spiess PE; Poch MA; Sexton WJ; Black PC; McKiernan JM; Steinberg GD; Kamat AM; Gilbert SM
    Eur Urol; 2020 Sep; 78(3):387-399. PubMed ID: 32143924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
    Pérez-Jacoiste Asín MA; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Tejido Á; San Juan R; Arrebola-Pajares A; Lizasoain M; Prieto S; Aguado JM
    Medicine (Baltimore); 2014 Oct; 93(17):236-254. PubMed ID: 25398060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: A systematic review.
    Cabas P; Rizzo M; Giuffrè M; Antonello RM; Trombetta C; Luzzati R; Liguori G; Di Bella S
    Urol Oncol; 2021 Feb; 39(2):85-92. PubMed ID: 33308969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance versus non-maintenance intravesical Bacillus Calmette-Guerin instillation for non-muscle invasive bladder cancer: A systematic review and meta-analysis of randomized clinical trials.
    Chen S; Zhang N; Shao J; Wang X
    Int J Surg; 2018 Apr; 52():248-257. PubMed ID: 29499363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculous spondylitis following intravesical bcg-instillation in the treatment of transitional cell carcinoma: Case report and systematic review.
    Broekx S; Buelens E
    Clin Neurol Neurosurg; 2020 Jul; 194():105944. PubMed ID: 32480296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.
    Gandhi NM; Morales A; Lamm DL
    BJU Int; 2013 Aug; 112(3):288-97. PubMed ID: 23517232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
    Babjuk M; Burger M; Compérat EM; Gontero P; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Zigeuner R; Capoun O; Cohen D; Escrig JLD; Hernández V; Peyronnet B; Seisen T; Soukup V
    Eur Urol; 2019 Nov; 76(5):639-657. PubMed ID: 31443960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failed endovascular abdominal aortic aneurysm repair due to
    Nishizawa M; Kudo T; Kijima T; Fujii Y
    J Vasc Surg Cases Innov Tech; 2022 Dec; 8(4):807-812. PubMed ID: 36507086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.